secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evelo Biosciences, Inc. (—)
CIK:        0001694665
Form:       8-K
Filed at:   2023-06-29T23:59:59+00:00
Accession:  0001694665-23-000100
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evelo Biosciences completes 1-for-20 reverse stock split; trading begins June 30
--------------------------------------------------------------------------------

- Approved by stockholders on June 8, 2023; Board set ratio at 1-for-20 on June 27.
- Reverse stock split became effective at 5:00 pm ET on June 29, 2023.
- Every 20 existing shares converted into 1 share; no fractional shares issued, cash in lieu.
- Trading on split-adjusted basis expected to start June 30 under symbol EVLO; new CUSIP: 299734202.
- Number of authorized shares and par value unchanged; adjustments made to equity awards and warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1694665/000169466523000100/0001694665-23-000100-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1694665/000169466523000100/evlo-20230629.htm
  HTML page:      https://secwatch.observer/filing/0001694665-23-000100

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer